ESR1 and breast cancer: The observed growth arrest is consistent with the degradation of BRD4 and the suppression of downstream c-Myc as well as with previous studies by our laboratory and others demonstrating c-Myc to be upregulated in ER+ breast cancer and involved in breast cancer proliferation (52, 54, 55).